カルシウム拮抗薬の世界市場レポート2020

• 英文タイトル：Global Calcium Antagonists Sales Market Report 2020

• レポートコード：20QY06-01448 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、カルシウム拮抗薬のグローバル市場について種類別（ジヒドロピリジン、ジルチアゼム、ベラパミル、その他）、用途別（高血圧、冠動脈疾患、不整脈、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・カルシウム拮抗薬市場の概要 ・世界の主要地域別カルシウム拮抗薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のカルシウム拮抗薬市場規模2015-2026：種類別（ジヒドロピリジン、ジルチアゼム、ベラパミル、その他） ・世界のカルシウム拮抗薬市場規模2015-2026：用途別（高血圧、冠動脈疾患、不整脈、その他） ・カルシウム拮抗薬の北米市場規模2015-2020 ・カルシウム拮抗薬のヨーロッパ市場規模2015-2020 ・カルシウム拮抗薬の中国市場規模2015-2020 ・カルシウム拮抗薬の日本市場規模2015-2020 ・カルシウム拮抗薬の東南アジア市場規模2015-2020 ・カルシウム拮抗薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、、Aventis、、Searle、、Bayer、、AstraZeneca、、Knoll Pharmaceuticals、、Wyeth-Ayerst、、Novartis、、Sanofi、、Baiyunshan Pharmaceutical、、South China Pharmaceutical Group、、Tianjin Tanabe Seiyaku、） ・カルシウム拮抗薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・カルシウム拮抗薬の市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Calcium Antagonists Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Calcium Antagonists market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.

N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.

CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Calcium Antagonists market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Calcium Antagonists industry.

Based on our recent survey, we have several different scenarios about the Calcium Antagonists YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Calcium Antagonists will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

QY Research report provides an overview and scope of the global Calcium Antagonists market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Calcium Antagonists market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.

QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Calcium Antagonists market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Calcium Antagonists market. The report also includes nautical information, where it shows Calcium Antagonists market product volume, utilization value, and production processes.

The research report also consists of a competitive landscape that describes the top players that are functioning in the global Calcium Antagonists market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Calcium Antagonists market.

Geographical Analysis:

Based on region, the global Calcium Antagonists market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Calcium Antagonists market are

Pfizer

Aventis

Searle

Bayer

AstraZeneca

Knoll Pharmaceuticals

Wyeth-Ayerst

Novartis

Sanofi

Baiyunshan Pharmaceutical

South China Pharmaceutical Group

Tianjin Tanabe Seiyaku

Segment by Type

Dihydropyridine

Diltiazem

Verapamil

Others

Segment by Application

Hypertension

Coronary Artery Disease

Arrhythmia

Ohers

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Calcium Antagonists market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Calcium Antagonists market.

• The market share of the global Calcium Antagonists market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

• Current and future market trends that are influencing the growth opportunities and growth rate of the global Calcium Antagonists market.

• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Calcium Antagonists market.

レポート目次

---

1 Calcium Antagonists Market Overview

1.1 Calcium Antagonists Product Scope

1.2 Calcium Antagonists Segment by Type

1.2.1 Global Calcium Antagonists Sales by Type (2020-2026)

1.2.2 Dihydropyridine

1.2.3 Diltiazem

1.2.4 Verapamil

1.2.5 Others

1.3 Calcium Antagonists Segment by Application

1.3.1 Global Calcium Antagonists Sales Comparison by Application (2020-2026)

1.3.2 Hypertension

1.3.3 Coronary Artery Disease

1.3.4 Arrhythmia

1.3.5 Ohers

1.4 Calcium Antagonists Market Estimates and Forecasts (2015-2026)

1.4.1 Global Calcium Antagonists Sales Growth Rate (2015-2026)

1.4.2 Global Calcium Antagonists Revenue and Growth Rate (2015-2026)

1.4.3 Global Calcium Antagonists Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Calcium Antagonists Industry Impact

1.5.1 How the Covid-19 is Affecting the Calcium Antagonists Industry

1.5.1.1 Calcium Antagonists Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Calcium Antagonists Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Calcium Antagonists Players to Combat Covid-19 Impact

2 Calcium Antagonists Estimate and Forecast by Region

2.1 Global Calcium Antagonists Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Calcium Antagonists Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Calcium Antagonists Sales Market Share by Region (2015-2020)

2.2.2 Global Calcium Antagonists Revenue Market Share by Region (2015-2020)

2.3 Global Calcium Antagonists Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Calcium Antagonists Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Calcium Antagonists Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Calcium Antagonists Estimates and Projections (2015-2026)

2.4.2 Europe Calcium Antagonists Estimates and Projections (2015-2026)

2.4.3 China Calcium Antagonists Estimates and Projections (2015-2026)

2.4.4 Japan Calcium Antagonists Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Calcium Antagonists Estimates and Projections (2015-2026)

2.4.6 India Calcium Antagonists Estimates and Projections (2015-2026)

3 Global Calcium Antagonists Competition Landscape by Players

3.1 Global Top Calcium Antagonists Players by Sales (2015-2020)

3.2 Global Top Calcium Antagonists Players by Revenue (2015-2020)

3.3 Global Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Antagonists as of 2019)

3.4 Global Calcium Antagonists Average Price by Company (2015-2020)

3.5 Manufacturers Calcium Antagonists Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Calcium Antagonists Players (Opinion Leaders)

4 Global Calcium Antagonists Market Size by Type

4.1 Global Calcium Antagonists Historic Market Review by Type (2015-2020)

4.1.1 Global Calcium Antagonists Sales Market Share by Type (2015-2020)

4.1.2 Global Calcium Antagonists Revenue Market Share by Type (2015-2020)

4.1.3 Global Calcium Antagonists Price by Type (2014-2020)

4.2 Global Calcium Antagonists Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Calcium Antagonists Sales Forecast by Type (2021-2026)

4.2.2 Global Calcium Antagonists Revenue Forecast by Type (2021-2026)

4.2.3 Global Calcium Antagonists Price Forecast by Type (2021-2026)

5 Global Calcium Antagonists Market Size by Application

5.1 Global Calcium Antagonists Historic Market Review by Application (2015-2020)

5.1.1 Global Calcium Antagonists Sales Market Share by Application (2015-2020)

5.1.2 Global Calcium Antagonists Revenue Market Share by Application (2015-2020)

5.1.3 Global Calcium Antagonists Price by Application (2015-2020)

5.2 Global Calcium Antagonists Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Calcium Antagonists Sales Forecast by Application (2021-2026)

5.2.2 Global Calcium Antagonists Revenue Forecast by Application (2021-2026)

5.2.3 Global Calcium Antagonists Price Forecast by Application (2021-2026)

3 North America Calcium Antagonists Market Facts & Figures

3.2 North America Calcium Antagonists Sales Market Share by Company (2015-2020)

3.3 North America Calcium Antagonists Sales Market Share by Type (2015-2020)

3.4 North America Calcium Antagonists Sales Market Share by Application (2015-2020)

4 Europe Calcium Antagonists Market Facts & Figures

4.2 Europe Calcium Antagonists Sales Market Share by Company (2015-2020)

4.3 Europe Calcium Antagonists Sales Market Share by Type (2015-2020)

4.4 Europe Calcium Antagonists Sales Market Share by Application (2015-2020)

5 China Calcium Antagonists Market Facts & Figures

5.2 China Calcium Antagonists Sales Market Share by Company (2015-2020)

5.3 China Calcium Antagonists Sales Market Share by Type (2015-2020)

5.4 China Calcium Antagonists Sales Market Share by Application (2015-2020)

6 Japan Calcium Antagonists Market Facts & Figures

6.2 Japan Calcium Antagonists Sales Market Share by Company (2015-2020)

6.3 Japan Calcium Antagonists Sales Market Share by Type (2015-2020)

6.4 Japan Calcium Antagonists Sales Market Share by Application (2015-2020)

7 Southeast Asia Calcium Antagonists Market Facts & Figures

7.2 Southeast Asia Calcium Antagonists Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Calcium Antagonists Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Calcium Antagonists Sales Market Share by Application (2015-2020)

8 India Calcium Antagonists Market Facts & Figures

8.2 India Calcium Antagonists Sales Market Share by Company (2015-2020)

8.3 India Calcium Antagonists Sales Market Share by Type (2015-2020)

8.4 India Calcium Antagonists Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Calcium Antagonists Business

12.1 Pfizer

12.1.1 Pfizer Calcium Antagonists Corporation Information

12.1.2 Pfizer Calcium Antagonists Business Overview and Total Revenue

12.1.3 Pfizer Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Pfizer Calcium Antagonists Products Offered

12.1.5 Pfizer Recent Development

12.2 Aventis

12.2.1 Aventis Calcium Antagonists Corporation Information

12.2.2 Aventis Calcium Antagonists Business Overview and Total Revenue

12.2.3 Aventis Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Aventis Calcium Antagonists Products Offered

12.2.5 Aventis Recent Development

12.3 Searle

12.3.1 Searle Calcium Antagonists Corporation Information

12.3.2 Searle Calcium Antagonists Business Overview and Total Revenue

12.3.3 Searle Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Searle Calcium Antagonists Products Offered

12.3.5 Searle Recent Development

12.4 Bayer

12.4.1 Bayer Calcium Antagonists Corporation Information

12.4.2 Bayer Calcium Antagonists Business Overview and Total Revenue

12.4.3 Bayer Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Bayer Calcium Antagonists Products Offered

12.4.5 Bayer Recent Development

12.5 AstraZeneca

12.5.1 AstraZeneca Calcium Antagonists Corporation Information

12.5.2 AstraZeneca Calcium Antagonists Business Overview and Total Revenue

12.5.3 AstraZeneca Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.5.4 AstraZeneca Calcium Antagonists Products Offered

12.5.5 AstraZeneca Recent Development

12.6 Knoll Pharmaceuticals

12.6.1 Knoll Pharmaceuticals Calcium Antagonists Corporation Information

12.6.2 Knoll Pharmaceuticals Calcium Antagonists Business Overview and Total Revenue

12.6.3 Knoll Pharmaceuticals Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Knoll Pharmaceuticals Calcium Antagonists Products Offered

12.6.5 Knoll Pharmaceuticals Recent Development

12.7 Wyeth-Ayerst

12.7.1 Wyeth-Ayerst Calcium Antagonists Corporation Information

12.7.2 Wyeth-Ayerst Calcium Antagonists Business Overview and Total Revenue

12.7.3 Wyeth-Ayerst Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Wyeth-Ayerst Calcium Antagonists Products Offered

12.7.5 Wyeth-Ayerst Recent Development

12.8 Novartis

12.8.1 Novartis Calcium Antagonists Corporation Information

12.8.2 Novartis Calcium Antagonists Business Overview and Total Revenue

12.8.3 Novartis Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Novartis Calcium Antagonists Products Offered

12.8.5 Novartis Recent Development

12.9 Sanofi

12.9.1 Sanofi Calcium Antagonists Corporation Information

12.9.2 Sanofi Calcium Antagonists Business Overview and Total Revenue

12.9.3 Sanofi Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Sanofi Calcium Antagonists Products Offered

12.9.5 Sanofi Recent Development

12.10 Baiyunshan Pharmaceutical

12.10.1 Baiyunshan Pharmaceutical Calcium Antagonists Corporation Information

12.10.2 Baiyunshan Pharmaceutical Calcium Antagonists Business Overview and Total Revenue

12.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Products Offered

12.10.5 Baiyunshan Pharmaceutical Recent Development

12.11 South China Pharmaceutical Group

12.11.1 South China Pharmaceutical Group Calcium Antagonists Corporation Information

12.11.2 South China Pharmaceutical Group Calcium Antagonists Business Overview and Total Revenue

12.11.3 South China Pharmaceutical Group Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.11.4 South China Pharmaceutical Group Calcium Antagonists Products Offered

12.11.5 South China Pharmaceutical Group Recent Development

12.12 Tianjin Tanabe Seiyaku

12.12.1 Tianjin Tanabe Seiyaku Calcium Antagonists Corporation Information

12.12.2 Tianjin Tanabe Seiyaku Calcium Antagonists Business Overview and Total Revenue

12.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Revenue and Gross Margin (2015-2020)

12.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Products Offered

12.12.5 Tianjin Tanabe Seiyaku Recent Development

13 Calcium Antagonists Manufacturing Cost Analysis

13.1 Calcium Antagonists Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Calcium Antagonists

13.4 Calcium Antagonists Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Calcium Antagonists Distributors List

14.3 Calcium Antagonists Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Calcium Antagonists Sales (K Units) Growth Rate by Type (2020-2026)

Table 2. Global Calcium Antagonists Sales (K Units) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Calcium Antagonists Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Calcium Antagonists Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Calcium Antagonists Players to Combat Covid-19 Impact

Table 8. Global Market Calcium Antagonists Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Calcium Antagonists Sales (K Units) by Region (2015-2020)

Table 10. Global Calcium Antagonists Sales Market Share by Region (2015-2020)

Table 11. Global Calcium Antagonists Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Calcium Antagonists Revenue Share by Region (2015-2020)

Table 13. Global Calcium Antagonists Sales (K Units) Forecast by Region (2021-2026)

Table 14. Global Calcium Antagonists Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Calcium Antagonists Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Calcium Antagonists Revenue Share Forecast by Region (2021-2026)

Table 17. Global Calcium Antagonists (K Units) of Key Companies (2015-2020)

Table 18. Global Calcium Antagonists Sales Share by Company (2015-2020)

Table 19. Global Calcium Antagonists Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Calcium Antagonists Revenue Share by Company (2015-2020)

Table 21. Global Calcium Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Calcium Antagonists as of 2019)

Table 22. Global Calcium Antagonists Average Price (USD/Unit) of Key Company (2015-2020)

Table 23. Manufacturers Calcium Antagonists Manufacturing Sites and Area Served

Table 24. Manufacturers Calcium Antagonists Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Calcium Antagonists Players

Table 27. Global Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 28. Global Calcium Antagonists Sales Share by Type (2015-2020)

Table 29. Global Calcium Antagonists Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Calcium Antagonists Price (K Units) by Type (2015-2020)

Table 31. Global Calcium Antagonists Sales Share by Type (2021-2026)

Table 32. Global Calcium Antagonists Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Calcium Antagonists Revenue Share by Type (2021-2026)

Table 34. Global Calcium Antagonists Price (K Units) by Type (2021-2026)

Table 35. Global Calcium Antagonists Sales (K Units) by Application (2015-2020)

Table 36. Global Calcium Antagonists Sales Share by Application (2015-2020)

Table 37. Global Calcium Antagonists Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Calcium Antagonists Price (K Units) by Application (2015-2020)

Table 39. Global Calcium Antagonists Sales (K Units) by Application (2021-2026)

Table 40. Global Calcium Antagonists Sales Share by Application (2021-2026)

Table 41. Global Calcium Antagonists Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Calcium Antagonists Revenue Share by Application (2021-2026)

Table 43. Global Calcium Antagonists Price (K Units) by Application (2021-2026)

Table 44. United States Calcium Antagonists Sales (K Units) by Company (2015-2020)

Table 45. United States Calcium Antagonists Sales Market Share by Company (2015-2020)

Table 46. United States Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 47. United States Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 48. United States Calcium Antagonists Sales (K Units) by Application (2015-2020)

Table 49. United States Calcium Antagonists Sales Market Share by Application (2015-2020)

Table 50. Europe Calcium Antagonists Sales (K Units) by Company (2015-2020)

Table 51. Europe Calcium Antagonists Sales Market Share by Company (2015-2020)

Table 52. Europe Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 53. Europe Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 54. Europe Calcium Antagonists Sales (K Units) by Application (2015-2020)

Table 55. Europe Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 56. China Calcium Antagonists Sales (K Units) by Company (2015-2020)

Table 57. China Calcium Antagonists Sales Market Share by Company (2015-2020)

Table 58. China Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 59. China Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 60. China Calcium Antagonists Sales (K Units) by Application (2015-2020)

Table 61. China Calcium Antagonists Sales Market Share by Application (2015-2020)

Table 62. Japan Calcium Antagonists Sales (K Units) by Company (2015-2020)

Table 63. Japan Calcium Antagonists Sales Market Share by Company (2015-2020)

Table 64. Japan Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 65. Japan Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 66. Japan Calcium Antagonists Sales (K Units) by Application (2015-2020)

Table 67. Japan Calcium Antagonists Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Calcium Antagonists Sales (K Units) by Company (2015-2020)

Table 69. Southeast Asia Calcium Antagonists Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 71. Southeast Asia Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 73. Southeast Asia Calcium Antagonists Sales Market Share by Application (2015-2020)

Table 74. India Calcium Antagonists Sales (K Units) by Company (2015-2020)

Table 75. India Calcium Antagonists Sales Market Share by Company (2015-2020)

Table 76. India Calcium Antagonists Sales (K Units) by Type (2015-2020)

Table 77. India Calcium Antagonists Sales Market Share by Type (2015-2020)

Table 78. India Calcium Antagonists Sales (K Units) by Application (2015-2020)

Table 79. India Calcium Antagonists Sales Market Share by Application (2015-2020)

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 83. Pfizer Calcium Antagonists Product

Table 84. Pfizer Recent Development

Table 85. Aventis Corporation Information

Table 86. Aventis Description and Business Overview

Table 87. Aventis Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 88. Aventis Calcium Antagonists Product

Table 89. Aventis Recent Development

Table 90. Searle Corporation Information

Table 91. Searle Description and Business Overview

Table 92. Searle Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 93. Searle Calcium Antagonists Product

Table 94. Searle Recent Development

Table 95. Bayer Corporation Information

Table 96. Bayer Description and Business Overview

Table 97. Bayer Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 98. Bayer Calcium Antagonists Product

Table 99. Bayer Recent Development

Table 100. AstraZeneca Corporation Information

Table 101. AstraZeneca Description and Business Overview

Table 102. AstraZeneca Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 103. AstraZeneca Calcium Antagonists Product

Table 104. AstraZeneca Recent Development

Table 105. Knoll Pharmaceuticals Corporation Information

Table 106. Knoll Pharmaceuticals Description and Business Overview

Table 107. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 108. Knoll Pharmaceuticals Calcium Antagonists Product

Table 109. Knoll Pharmaceuticals Recent Development

Table 110. Wyeth-Ayerst Corporation Information

Table 111. Wyeth-Ayerst Description and Business Overview

Table 112. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 113. Wyeth-Ayerst Calcium Antagonists Product

Table 114. Wyeth-Ayerst Recent Development

Table 115. Novartis Corporation Information

Table 116. Novartis Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 117. Novartis Description and Business Overview

Table 118. Novartis Calcium Antagonists Product

Table 119. Novartis Recent Development

Table 120. Sanofi Corporation Information

Table 121. Sanofi Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 122. Sanofi Description and Business Overview

Table 123. Sanofi Calcium Antagonists Product

Table 124. Sanofi Recent Development

Table 125. Baiyunshan Pharmaceutical Corporation Information

Table 126. Baiyunshan Pharmaceutical Description and Business Overview

Table 127. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 128. Baiyunshan Pharmaceutical Calcium Antagonists Product

Table 129. Baiyunshan Pharmaceutical Recent Development

Table 130. South China Pharmaceutical Group Corporation Information

Table 131. South China Pharmaceutical Group Description and Business Overview

Table 132. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table 133. South China Pharmaceutical Group Calcium Antagonists Product

Table 134. South China Pharmaceutical Group Recent Development

Table . Tianjin Tanabe Seiyaku Corporation Information

Table . Tianjin Tanabe Seiyaku Description and Business Overview

Table . Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)

Table . Tianjin Tanabe Seiyaku Calcium Antagonists Product

Table . Tianjin Tanabe Seiyaku Recent Development

Table 140. Production Base and Market Concentration Rate of Raw Material

Table 141. Key Suppliers of Raw Materials

Table 142. Calcium Antagonists Distributors List

Table 143. Calcium Antagonists Customers List

Table 144. Market Key Trends

Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 146. Key Challenges

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Calcium Antagonists Product Picture

Figure 2. Global Calcium Antagonists Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Calcium Antagonists Market Share by Application in 2020 & 2026

Figure 6. Hypertension Examples

Figure 7. Coronary Artery Disease Examples

Figure 8. Arrhythmia Examples

Figure 9. Ohers Examples

Figure 10. Global Calcium Antagonists Sales (K Units) Growth Rate (2015-2026)

Figure 11. Global Calcium Antagonists Revenue (US$ Million) Growth Rate (2015-2026)

Figure 12. Global Calcium Antagonists Price Trends Growth Rate (2015-2026) (USD/Unit)

Figure 13. Global Calcium Antagonists Revenue Market Share by Region: 2015 VS 2020

Figure 14. Global Calcium Antagonists Revenue Market Share by Region: 2021 VS 2026

Figure 15. United States Calcium Antagonists Revenue (Million USD) Growth Rate (2015-2026)

Figure 16. United States Calcium Antagonists Sales (K Units) Growth Rate (2015-2026)

Figure 17. Europe Calcium Antagonists Revenue (Million USD) Growth Rate (2015-2026)

Figure 18. Europe Calcium Antagonists Sales (Million USD) Growth Rate (2015-2026)

Figure 19. China Calcium Antagonists Revenue (Million USD) Growth Rate (2015-2026)

Figure 20. China Calcium Antagonists Sales (Million USD) and Growth Rate (2015-2026)

Figure 21. Japan Calcium Antagonists Revenue (Million USD) Growth Rate (2015-2026)

Figure 22. Japan Calcium Antagonists Sales (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Calcium Antagonists Revenue (Million USD) Growth Rate (2015-2026)

Figure 24. Southeast Asia Calcium Antagonists Sales (Million USD) Growth Rate (2015-2026)

Figure 25. India Calcium Antagonists Revenue (Million USD) Growth Rate (2015-2026)

Figure 26. India Calcium Antagonists Sales (Million USD) Growth Rate (2015-2026)

Figure 27. Global 5 Largest Calcium Antagonists Players Market Share by Revenue in Calcium Antagonists 2015 & 2019

Figure 28. Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 29. Global Calcium Antagonists Revenue Share by Type (2015-2020)

Figure 30. Global Calcium Antagonists Revenue Growth Rate by Type in 2015 & 2019

Figure 31. Global Calcium Antagonists Revenue Share by Application (2015-2020)

Figure 32. Global Calcium Antagonists Revenue Growth Rate by Application in 2015 & 2019

Figure 33. United States Calcium Antagonists Sales Market Share by Type in 2019

Figure 34. United States Calcium Antagonists Sales Market Share by Type in 2019

Figure 35. Europe Calcium Antagonists Sales Market Share by Company in 2019

Figure 36. Europe Calcium Antagonists Sales Market Share by Type in 2019

Figure 37. Europe Calcium Antagonists Sales Market Share by Application in 2019

Figure 38. China Calcium Antagonists Sales Market Share by Company in 2019

Figure 39. China Calcium Antagonists Sales Market Share by Type in 2019

Figure 40. China Calcium Antagonists Sales Market Share by Application in 2019

Figure 41. Japan Calcium Antagonists Sales Market Share by Company in 2019

Figure 42. Japan Calcium Antagonists Sales Market Share by Type in 2019

Figure 43. Japan Calcium Antagonists Sales Market Share by Application in 2019

Figure 44. Southeast Asia Calcium Antagonists Sales Market Share by Company in 2019

Figure 45. Southeast Asia Calcium Antagonists Sales Market Share by Type in 2019

Figure 46. Southeast Asia Calcium Antagonists Sales Market Share by Application in 2019

Figure 47. India Calcium Antagonists Sales Market Share by Company in 2019

Figure 48. India Calcium Antagonists Sales Market Share by Type in 2019

Figure 49. India Calcium Antagonists Sales Market Share by Application in 2019

Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Aventis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Searle Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Knoll Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Wyeth-Ayerst Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Baiyunshan Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. South China Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 61. Tianjin Tanabe Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Key Raw Materials Price Trend

Figure 63. Manufacturing Cost Structure of Calcium Antagonists

Figure 64. Manufacturing Process Analysis of Calcium Antagonists

Figure 65. Calcium Antagonists Industrial Chain Analysis

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

Figure 68. Porter's Five Forces Analysis

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

---